MedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial Results
30 March 2023 - 11:30PM
MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the
“Company”), an innovative pharmacy technology company, announced
today that it is postponing its scheduled earnings release and
conference call for the fourth quarter and full-year ended December
31, 2022 previously scheduled for today.
The Company requires additional time to complete
the preparation and corresponding audit of its consolidated
condensed financial statements as of and for the year ended
December 31, 2022. In connection with the Company’s divestiture of
its pharmacy services business, the Company and its auditors need
more time to complete their year-end procedures and reporting. The
Company plans to file a timely Notification Late Filing on Form
12b-25 to extend the filing deadline for the Company’s Annual
Report on Form 10-K for the fiscal year ended December 31,
2022.
The Company will announce the date and time of
its scheduled fourth quarter and full-year ended December 31, 2022
financial results and conference call in a future press
release.
About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a
technology-enabled pharmacy company, providing turnkey in-clinic
pharmacy services through its proprietary robotic dispensing
platform, the MedAvail MedCenter, to Medicare clinics, urgent care
clinics, large healthcare systems, mass merchandise retailers,
hospital systems and other healthcare channels. MedAvail helps
patients to optimize drug adherence, resulting in better health
outcomes. Learn more at www.medavail.com.
Forward-Looking Statements
Certain statements included in this press
release that are not historical facts are forward-looking
statements for purposes of the safe harbor provisions under the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements generally are accompanied by words such as "believe,"
"may," "will," "estimate," "continue," "anticipate," "intend,"
"expect," "should," "would," "plan," "predict," "potential,"
"seem," "seek," "future," "outlook," "project," and similar
expressions that predict or indicate future events or trends or
that are not statements of historical matters. These
forward-looking statements are based on various assumptions,
whether or not identified in this press release, and on the current
expectations of MedAvail's management and are not predictions of
actual performance. Forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
to differ materially from the forward-looking statements, including
but not limited to our ability to successfully achieve the benefits
of a pharmacy technology only business and the efficiencies related
to a restructuring and reorganization, and risks relating to our
ability to successfully consummate potential strategic, financing
and restructuring transactions, as well as other risks discussed
under the heading "Risk Factors" in MedAvail’s recent Annual Report
on Form 10-K and MedAvail’s Quarterly Reports on Form 10-Q,and
other filings MedAvail makes with the Securities and Exchange
Commission (“SEC”) in the future. If any of these risks materialize
or our assumptions prove incorrect, actual results could differ
materially from the results implied by these forward-looking
statements. These forward-looking statements speak only as of the
date hereof and MedAvail specifically disclaims any obligation to
update these forward-looking statements.
Contacts:
Investor RelationsInvestor RelationsSteven
Halper/Caroline PaulManaging Directors, LifeSci
Advisorsir@medavail.com
SOURCE MedAvail Holdings, Inc.
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jun 2024 to Jul 2024
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jul 2023 to Jul 2024